WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims data

Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in a federal drug discount program.

Raccontata daforbes.comstatnews.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
statnews.comStai leggendo22 h fa

Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims data

Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in a federal drug discount program.

originale
forbes.com3 g fa

What’s Behind Pharma’s Attack On Hospitals? Understanding The 340B Program

A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing policy debate.

Leggi questa versione → originale

Timeline cronologica

  1. martedì 16 giugno 2026·forbes.com

    What’s Behind Pharma’s Attack On Hospitals? Understanding The 340B Program

    A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing policy debate.

  2. giovedì 18 giugno 2026·statnews.com

    Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims data

    Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in a federal drug discount program.